All trans retinoic acid and cancer

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 2, 2011, Pages 241-249

  Siddikuzzaman, ^a   Guruvayoorappan, C ^a   Berlin Grace, V M ^a  

^a KARUNYA UNIVERSITY   (India)

Author keywords

acute promyelocytic leukemia (APL); All trans retinoic acid (ATRA); anti angiogenic; anti inflammatory; chemopreventive; chemotherapeutic; retinoic acid receptors; retinoid; retinoid receptors (RXRs)

Indexed keywords

4 OXOISOTRETINOIN; ALITRETINOIN; RETINOIC ACID; RETINOID; RETINOL;

CANCER PREVENTION; CLINICAL TRIAL; DIETARY INTAKE; DRUG ACTIVITY; DRUG BINDING; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSFORMATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 79955856297     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2010.521507     Document Type: Review

References (130)

1. Gropper SS, Smith JL, Grof JL. Advanced Nutrition and Human Metabolism 5th Edition, 2009: 373-1182.
2. Lotan R. Retinoids as modulators of tumor cells invasion and metastasis. Semin Cancer Biol 1991; 2: 197-208.
3. Hofmann SL. Retinoids-"diferentiation agents" for cancer treatment and prevention. Am J Med Sci 1992; 304: 202-13.
4. McBurney MW, Costa S, Pratt MA. Retinoids and cancer: a basis for diferentiation therapy. Cancer Invest 1993; 11: 590-8. (Pubitemid 23281855)
5. Fanjul AN, Delia D, Pierotti MA, Rideout D, Yu JQ, Pfahl M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem 1996; 271: 22441-6. (Pubitemid 26304679)
6. Lokshin A, Zhang H, Mayotte J, Lokshin M, Levitt ML. Early efects of retinoic acid on proliferation, diferentiation and apoptosis in nonsmall cell lung cancer cell lines. Anticancer Res 1999; 19: 5251-4. (Pubitemid 30103357)
7. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
8. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a diferentiation therapy for acute promyelocytic leukemia: I. Clinical results. Blood 1990; 76: 1704-1709.
9. Kim DG, Jo BH, You KR, Ahn DS. Apoptosis induced by retinoic acid in Hep3B cells in vitro. Cancer Lett 1996; 107: 149-159. (Pubitemid 26370871)
10. Hayashi K, Yokozaki H, Naka K, Yasui W, Lotan R, Tahara E. Overexpression of retinoic acid receptor ß induces growth arrest and apoptosis in oral cancer cells. Jpn J Cancer Res 2001; 92: 42-50. (Pubitemid 32175477)
11. Choi Y Kim SY, Kim SH, Yang J, Park K, Byun Y. Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer 2003; 107: 145-148. (Pubitemid 37100099)
12. Lee YF, Bao BY Chang C. Modulation of the retinoic acid-induced cell apoptosis and diferentiation by the human TR4 orphan nuclear receptor. Biochem Biophys Res Commun 2004; 323: 876-883.
13. Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C, Cummins JM, Velculescu VE, Fults DW, McLendon RE, Bigner DD, Yan H. Identifcation of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 2005; 65: 919-924. (Pubitemid 40216452)
14. Edgar W: "Steroid/Tyroid Hormone Receptors". Gene Regulation in Eukaryotes. New York: VCH: 1993;316.
15. Holland LZ. ",Developmental biology: A chordate with a diference". Nature 2007; 447: 153-155.
16. DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal S. Identifcation and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci U. S. A. 1998; 95: 14811-14815. (Pubitemid 29003712)
17. Deucher A, Nagpal S, Chandraratna RA, DiSepio D, Robinson NA, Dashti SR, Eckert RL. Te carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol 2000; 17: 1195-1203.
18. Higuchi E, Chandraratna RA, Hong WK, Lotan R. Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 2003; 22: 4627-4635. (Pubitemid 36976436)
19. Sommer A. Vitamin A Defciency and Clinical Disease: An Historical Overview. J Nutr 2008; 138: 1835-1839.
20. Levin AA. Receptors as tools for understanding the toxicity of retinoids. Toxicol Lett 1995; 82/83: 91-97. (Pubitemid 26057498)
21. Kim YW, Sharma RP, Li JK. Characterization of heterologously expressed recombinant retinoic acid receptors with natural or synthetic retinoids. J Biochem Toxicol 1994; 9: 225-234.
22. Repa JJ, Hanson KK, Clagett-Dame M. All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA 1993; 90: 7293-7297. (Pubitemid 23222436)
23. Levin AA, Bosakowski T, Kazmer S, Grippo JF. 13-cis-Retinoic acid does not bind to the retinoic acid receptors alpha, beta, and gamma. Toxicologist 1992; 12:181.
24. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Taller C. 9-cis-Retinoic acid is a high-afnity ligand for retinoid X receptor. Cell 1992; 68:397-406.
25. Creech KJ, Juchau MR. 9-cis-Retinoic acid: a direct-acting dysmorphogen. Biochem Pharmacol 1993b; 46: 709-717.
26. Creech KJ, Schuh T, Juchau MR, Kimelman D. Te retinoid X receptor ligand, 9-cis-retinoic acid, as an apparent regulator of early Xenopus development. Proc Natl Acad Sci USA 1994; 91: 3067-3071. (Pubitemid 24130176)
27. Napoli JL. Retinoic acid biosynthesis and metabolism. FASEB J 1996; 10: 993-1001. (Pubitemid 26285975)
28. Zile MH, Emerick RJ, DeLuca HF. Identifcation of 13-cis-retinoic acid in tissue extracts and its biological activity in rats. Biochim Biophys Acta 1967; 141: 639-641.
29. Zile MH, Inhorn RC, DeLuca HF. Metabolism in vivo of all-trans-retinoic acid: biosynthesis of 13-cis-retinoic acid and all-trans-and 13-cis-retinoyl glucuronides in the intestinal mucosa of rat. J Biol Chem 1982; 257: 3544-3550. (Pubitemid 12077136)
30. Kalin JR, Starling ME, Hill DL. Disposition of all-trans-retinoic acid in mice following oral doses. Drug Metab Dispos 1981; 9: 196-201. (Pubitemid 11039413)
31. Sundaresan PR, Bhat PV. Ion-pair high-pressure liquid chromatography of cis-trans isomers of retinoic acid in tissues of vitamin A-sufcient rats. J Lipid Res 1982; 23: 448-455. (Pubitemid 12094757)
32. Kojima R, Fujimori T, Kiyota N, Toriya Y, Fukuda T, Ohashi T, Sato T, Yoshizawa Y, Takeyama K, Mano H, Masushige S, Kato S. In vitro isomerization of retinoic acids: rapid isomer exchange and gene expression. J Biol Chem 1994; 269: 32700-32707.
33. Shih TW, Shealy YF, Strother DL, Hill DL. Nonenzymatic isomerization of all-transand 13-cis-retinoids catalyzed by sulfhydryl groups. Drug Metab Dispos 1986; 14: 698-702. (Pubitemid 17202409)
34. Urbach J, Rando RR. Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. Biochem J 1994a; 299: 459-465. (Pubitemid 24114140)
35. Shih TW, Lin T-H, Shealy YF, Hill DL. Nonenzymatic isomerization of 9-cis-retinoic acid catalyzed by sulfhydryl compounds. Drug Metab Dispos 1997; 25: 27-32. (Pubitemid 27045130)
36. Urbach J, Rando RR. Tiol dependent isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. FEBS Lett 1994b; 351: 429-432. (Pubitemid 24285351)
37. Chen H, Juchau MR. Biotransformation of all-trans-retinal, 13-cis-retinal, and 9-cisretinal catalyzed by conceptal cytosol and microsomes. Biochem Pharmacol 1997; 53: 877-885. (Pubitemid 27145790)
38. Napoli JL. Retinoic acid: its biosynthesis and metabolism. Prog Nucleic Acid Res Mol Biol 1999; 63: 139-188.
39. Samokyszyn VM, Gall WE, Zawada G, Freyaldenhoven MA, Chen G, Mackenzie PI, Tephly TR, Radominska-Pandya A. 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem 2000; 275: 6908-6914. (Pubitemid 30146232)
40. Marill J, Cresteil T, Lanotte M, Chabot GG. Identifcation of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 2000; 58: 1341-1348.
41. Ray WJ, Bain G, Yao M, Gottlieb DI. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defnes a new family. J Biol Chem 1997; 272:18702-18708. (Pubitemid 27318214)
42. White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifes a novel family of cytochromes P450. J Biol Chem 1997; 272:18538-18541. (Pubitemid 27318190)
43. Creech KJ, Juchau MR. Xenopus laevis: A model system for the study of embryonic retinoid metabolism: III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis retinoic acid and their dysmorphogenic efects in embryos during neurulation. Drug Metab Dispos 1995; 23: 1058-1071.
44. Creech KJ, Kimelman D, Juchau MR. Xenopus laevis: A model system for the study of embryonic retinoid metabolism: I. Embryonic metabolism of 9-cis-and all-trans-retinals and retinols to their corresponding acid forms. Drug Metab Dispos 1995a; 23: 72-82.
45. Creech KJ, Kimelman D, Juchau MR. Xenopus laevis: A model system for the study of embryonic retinoid metabolism: II. Embry-onic metabolism of all-trans-3,4-didehydroretinol to all-trans-3,4-didehydroretinoic acid. Drug Metab Dispos 1995b; 23: 83-89.
46. Nau H. Teratogenesis, transplacental pharmacokinetics, and metabolism of some retinoids in the mouse, monkey, and human. In Retinoids: Progress in Research and Clinical Applications (M.A. Livreaand L. Packer, Eds.), pp. 599-616.
47. Barua AB, Gunning DB, Olson JA. Metabolism in vivo of all-trans-[11-3H] retinoic acid after an oral dose in rats. Biochem J 1991; 227: 527-531.
48. Blaner WS, Olson JA. Retinol and retinoic acid metabolism. In Te Retinoids: Biology, Chemistry and Medicine (M. B. Sporn, A. B. Roberts D.S Goodman, Eds.), 1994; 2nd ed,229-255.
49. Howard WB, Willhite CC, Omaye ST, Sharma RP. Comparative distribution, pharmacokinetics, and placental permeabilities of all-trans-retinoic acid, 13-cis-retinoic acid, all-trans-4-oxo-retinoic acid, retinyl acetate, and 9-cis-retinal in hamsters. Arch Toxicol 1989; 63: 112-120. (Pubitemid 19107369)
50. Pijnappel WWM, Hendriks HFJ, Folkers GE, Van den Brink CE, Dekker EJ, Edelenbosch C, Van der Saag PT, Durston AJ. Te retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specifcation. Nature 1993; 366: 340-344. (Pubitemid 23349360)
51. Gudas LJ. Retinoids and vertebrate development. J Biol Chem 1994; 269: 15399-15402. (Pubitemid 24202115)
52. Tate BF, Levin AA, Grippo JF. Te discovery of 9-cis retinoic acid: a hormone that binds the retinoid-X receptor.Trends Endocrinol Metab 1994; 5: 189-194. (Pubitemid 24266935)
53. Lavau C, Dejean A. Te t(15;17) translocation in acute promyelocytic leukemia. Leukemia 1994; 8: 1615-1621. (Pubitemid 24323774)
54. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors.Nature 1987; 330: 444-450. (Pubitemid 18006425)
55. Giguere V Ong ES, Segui P, Evans RM. Identifcation of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624-629. (Pubitemid 18005577)
56. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifes a novel retinoic acid response pathway. Nature 1990; 345: 224-229.
57. Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES, Evans RM. A direct repeat in the cellular retinol-binding protein type II gene confers diferential regulation by RXR and RAR. Cell 1991; 66: 555-561. (Pubitemid 121001391)
58. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329-344.
59. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Taller C. 9-cis retinoic acid is a high afnity ligand for the retinoid X receptor. Cell 1992; 68: 397-406.
60. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954. (Pubitemid 26285969)
61. Mangelsdorf DJ, Tummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. Te nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-839.
62. Napoli JL, Posch KP, Fiorella PD, Boerman MH. Physiological occurrence,biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis. Biomed Pharmacother 1991; 45: 131-143.
63. Ross AC Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. FASEB J 1993; 7: 317-327. (Pubitemid 23067782)
64. Donovan M, Olofsson B, Gustafson AL, Dencker L, Eriksson U. Te cellular retinoic acid binding proteins. J Steroid Biochem Mol Biol 1995; 53: 459-465.
65. Boylan JF, Gudas LJ. Te level of CRABP-I expression infuences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 1992; 267: 21486-21491.
66. Napoli JL, Boerman M, Chai X, Zhai Y, Fiorella PD. Enzymes and binding proteins afecting retinoic acid concentrations. J Steroid Biochem Mol Biol 1995; 53: 497-502.
67. Warrell RP Jr, de Té H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177.
68. Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P. All-trans-retinoic acid as a diferentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 85: 2643.
69. Huang M E, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
70. Castaigne S, Chomienne C, Daniel MT, Ballerini P,Berger R, Fenaux P, Degos L. All-trans retinoic acid as a diferentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76:1704-1709.
71. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreef M, Tafuri A, Jakubowski AJanice G, Michael SG, Ethan D. Diferentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991; 324: 1385-1393.
72. Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P. Proof of diferentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 1992; 79: 1916-1919.
73. Warrell RP, de Te H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177-189. (doi:10.1056/NEJM199307153290307) (Pubitemid 23195739)
74. Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to diferentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 1990; 79: 448-453. (Pubitemid 20082275)
75. Gianni M, Ponzanelli I, Mologni L, Reichert U,Rambaldi A, Terao M, Garattini E. Retinoiddependent growth inhibition, diferentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Difer 2000; 7: 447-460. (doi:10.1038/sj.cdd.4400673) (Pubitemid 30255713)
76. Altucci L, Rossin A, Rafelsberger W, Reitmair A,Chomienne C, Gronemeyer H. Retinoic acidinduced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand trail. Nat Med 2001; 7: 680-686. (doi:10.1038/89050) (Pubitemid 32588023)
77. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorf B, Doskeland SO, Lanotte M. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci USA 1994; 91: 8428-8432. (doi:10.1073/pnas.91.18.8428)
78. Zhu J, Lallemand-Breitenbach V, de Te H. Pathways of retinoic acid-or arsenic trioxide-induced PML/RARa catabolism: role of oncogene degradation in disease remission. Oncogene 2001; 20: 7257-7265. (doi:10.1038/sj.onc.1204852) (Pubitemid 33107375)
79. Zhu Q, Zhang JW, Zhu HQ, Shen YL, Flexor M, Jia PM, Yu Y, Cai X, Waxman S, Lanotte M, Chen SJ, Chen Z, Tong JH. Synergic efects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk. Blood 2002b; 99: 1014-1022. (doi:10.1182/bloodV99.7.2562) (Pubitemid 34525566)
80. Warrell RJ, de Té H, Wang ZY et al: Medical progress: acute promyelocytic leukemia. N Engl J Med 329: 177-189, 1993.
81. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a diferentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704-1709.
82. Warrell RJ, Frankel SR, Miller WJ et al. Diferentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385-1393, 1991.
83. Golomb HM, Rowley J, Vardiman J et al: Partial deletion of long arm of chromosome 17: a specifc abnormality in acute pro-myelocytic leukemia? Arch Intern Med 136: 825-828, 1976.
84. Rowley JD, Golomb HM, Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia (letter). Lancet 1977; 1: 549-550. (Pubitemid 8045927)
85. Mattei MG, Petkovich M, Mattei JF, Brand N, Chambon P. Mapping of the human retinoic acid receptor to the q21 band of chromosome 17. Hum Genet 1988; 80: 186-188.
86. Chomienne C, Ballerini P, Balitrand N et al: Te retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 4: 802-807, 1990.
87. De Té H, Chomienne C, Lanotte M et al: Te t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558-561, 1990.
88. Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577-1580.
89. Goddard AD, Borrow J, Freemont PS et al: Characterization of a zinc fnger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254: 1371-1374, 1991. (Pubitemid 21917471)
90. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663-674. (Pubitemid 121001702)
91. Early E, Dmitrovsky E: Acute promyelocytic leukemia: retinoic acid response and resistance. J Invest Med 1995; 43: 337-344.
92. Rousselot P, Hardas B, Patel A et al: Te PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic diferentiation and mediated transactivation in human myeloid cells. Oncogene 9: 545-551, 1994.
93. Breitman TR, Collins SJ, Keene BR. Terminal diferentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000-4. (Pubitemid 11050800)
94. Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreef M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E. Diferentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991; 324: 1385-93.
95. Slack JL. Biology and treatment of acute progranulocytic leukemia. Curr Opin Hematol 1999; 6: 236-40. (Pubitemid 29380463)
96. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815-8. (Pubitemid 28099683)
97. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349-52. (Pubitemid 27415209)
98. Heinzel T, Lavinsky RM, Mullen TM, SOderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 1997; 387: 43-8. (Pubitemid 27202643)
99. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 1999; 9: 40-8. (Pubitemid 29080385)
100. Collingwood TN, Urnov FD, Wolfe AP: Nuclear receptors. coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 1999; 23: 255-75. (Pubitemid 30055983)
101. Glass CK, Rosenfeld MG, Rose DW, Kurokawa R, Kamei Y, Xu L, Torchia J, Ogliastro MH, Westin S. Mechanisms of transcriptional activation by retinoic acid receptors. Biochem Soc Trans 1997; 25: 602-5. (Pubitemid 27260880)
102. Casini T, Pelicci PG. A function of p21 during promyelocytic leukemia cell diferentiation independent of CDK inhibition and cell cycle arrest. Oncogene 1999; 18: 3235-43. (Pubitemid 29286968)
103. Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart AF, Nakamaki T, Weinberg K, Koefer HP. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, diferentiation. Blood 1997; 90: 2591-600.
104. Pelicano L, Li F, Schindler C, Chelbi-Alix MK. Retinoic acid enhances the expression of interferon-induced proteins. Evidence for multiple mechanisms of action. Oncogene 1997; 15: 2349-59. (Pubitemid 27496985)
105. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 1994; 76: 345-56. (Pubitemid 24046696)
106. Agadir A, Cornic M, Jerome M, Menot ML, Cambier N, Gaub MP, Gourmel B, Lefebvre P, Degos L, Chomienne C. Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specifc uptake of ATRA and RAR alpha protein modulation. Biochem Biophys Res Commun 1995; 213: 112-22.
107. Chomienne C, Balitrand N, Ballerini P, Castaigne S, de Te H, Degos L. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J Clin Invest 1991; 88: 2150-4.
108. Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH. Te PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 1996; 88: 2826-32. (Pubitemid 26357362)
109. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-transretinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 1996; 56: 2945-8. (Pubitemid 26199737)
110. Mangelsdorf D J, Umesono K, Evans RM. Te retinoid receptors. In Te Retinoids: Biology, Chemistry and Medicine (M. B, Sporn, A.B. Roberts, and D.S Goodman, Eds.), 1994; 2nd ed., pp. 319-349. Raven Press, New York.
111. Lotan R. Efects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605: 33-91. (Pubitemid 10110754)
112. Zuccari G, Carosio R, Fini A, Montaldo PG, Orienti I. Modifed polyvinylalcohol for encapsulation of all-transretinoic acid in polymeric micelles. J Control Rel 2005; 103: 369-380. (Pubitemid 40342535)
113. Maiti TK, Ghosh KS, Debnath J, Dasgupta S. Binding of all-trans retinoic acid to human serum albumin: Fluorescence, FT-IR and circular dichroism studies. Int J Biol Macromol 2006; 38: 197-202.
114. Kini AR, Peterson LC, Tallman MS, Lingen MW. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood 2001; 97(12): 3919-3924.
115. Aylsworth CF, Cullum ME, Zile MH, Welsh CW. Infuence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by high levels of dietary fat. J Natl Cancer Inst 1986; 76: 339-345. (Pubitemid 16130017)
116. Munker M, Munker R, Saxton RE, Koefer HP. Efect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines. Cancer Res 1987; 47: 4081-4085. (Pubitemid 17108474)
117. Breitman TR, Selonick SE, Collins SJ. Induction of diferentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl Acad Sci U.S.A 1980; 77: 2936-2940.
118. Edward M, Gold JA, Mackie RM. Diferent susceptibilities of melanoma cells to retinoic acid-induced changes in melanotic expression. Biochem Biophys Res Commun 1988; 155: 773-778.
119. Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ. All-trans retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G-1. Exp Cell Res 1997a; 232: 277-286. (Pubitemid 27194040)
120. Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep 1987a; 71: 391-405. (Pubitemid 17070398)
121. Lippman SM, Kessler JF, Meyskens FL, Jr. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep 1987b; 71:493-514.
122. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonof S, Byers R, Atkinson EN, Vaughan C, Toth B, Kramer, Dimery IW, Lippman SM, Skipper P, Strong S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501-1505. (Pubitemid 17052146)
123. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H. Prevention of second primary tumors with Isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795-801. (Pubitemid 20303877)
124. Geisen C, Denk C, Gremm B et al: High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor α and is abnormally down-regulated in cervical carcinoma cells. Cancer Res 57: 1460-7, 1997. (Pubitemid 27175561)
125. Lotan R, Dawson MI, Zou CC, Jong L, Lotan D, Zou CP. Enhanced efcacy of combinations of retinoic acid-and retinoid X receptorselective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res 1995; 55: 232-236.
126. Surwit EA, Graham V, Droegemueller W et al: Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions. Am J Obstet Gynecol 1982; 143: 821-823. (Pubitemid 12093539)
127. Meyskens FL, Graham V, Chvapil M, Dorr RT, Alberts DS, Surwit EA. A phase I trial of h-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap formild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst 1983; 71: 921-925. (Pubitemid 14216471)
128. Berlin Grace VM, Niranjali Devaraj S, Radhakrishnan Pillai M, Devaraj H. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level. Gynecologic Oncology 2006; 103: 113-119. (Pubitemid 44374677)
129. Lippman SM, Batsakis JG, Toth BB, Weber R S, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15-20. (Pubitemid 23011466)
130. Mohsen SE, Mckinney K and Shanti MS. Vitamin A toxicity. 2008.